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ABSTRACT
Objectives To determine levels of awareness of
ovarian cancer symptoms and to identify barriers
to help-seeking and predictors of a longer time
to help-seeking in a UK female population-based
sample.
Methods A UK population-based sample of
women [n=1000, including a subsample of
women at higher risk due to their age (≥45
years, n=510)] completed the Ovarian Cancer
Awareness Measure by telephone interview.
Questions measured symptom awareness (using
recall and recognition), barriers to medical help-
seeking and anticipated time to help-seeking.
Regression analyses identified predictors of a
higher score on a scale of anticipated time to
help-seeking.
Results Most women (58% overall sample;
54% subgroup) were unable to recall any
symptoms but 99% recognised at least one.
Recognition was lowest for difficulty eating and
persistently feeling full. In the sample overall,
higher socio-economic status and higher
endorsement of practical and service barriers
independently predicted a longer anticipated
time to help-seeking for more symptoms. White
ethnicity was an additional predictor in the older
subgroup.
Conclusions This study suggests awareness of
ovarian cancer symptoms is low in the UK, and
varies widely between symptoms. It identifies
variables that may be involved in a longer time to
help-seeking for possible ovarian cancer
symptoms and highlights the need for more in-
depth research into the factors related to time to
help-seeking in real-world situations.
INTRODUCTION
Ovarian cancer is the most deadly
gynaecological cancer in the UK,1
responsible for more deaths than all the
other gynaecological malignancies
combined.2 The 1-year survival rate for
ovarian cancer in the UK is just 36%,
which is lower than survival rates
observed in comparable countries.3 This
suggests that ovarian cancer is diagnosed
later in the UK than elsewhere. In fact,
60% of ovarian cancers are diagnosed at
the latest stages (Stages III/IV, with asso-
ciated 5-year survival rates of just
6–22%).4 Increasing earlier stage diagno-
ses may therefore improve survival rates
so that they are in line with or even
better than those observed in other
countries.
In the absence of an effective ovarian
cancer screening strategy (feasibility trials
are currently being undertaken, with con-
clusions expected in 2015),5 early-stage
diagnosis is reliant upon timely patient
help-seeking and appropriate action by
health care professionals at patient pres-
entation (i.e. appropriate investigations
and/or referral to secondary care).
However, women do not always seek
help in a timely manner nor do they
always receive a timely diagnosis.6 This
paper focuses on the former issue.
Non-recognition of symptom serious-
ness (which may be the result of low
symptom awareness)7 appears to be the
most important patient-mediated factor
KEY MESSAGE POINTS
▸ Ovarian cancer symptom awareness is
low in the UK, and varies widely
between symptoms.
▸ Socio-economic status and barrier
endorsement predict longer time to help-
seeking in the sample overall. Ethnicity
was an additional predictor in the sub-
group of women aged ≥45 years.
ARTICLE
Low EL, et al. J Fam Plann Reprod Health Care 2013;39:163–171. doi:10.1136/jfprhc-2012-100473 163
 group.bmj.com on July 21, 2014 - Published by jfprhc.bmj.comDownloaded from 
leading to a longer time to help-seeking for ovarian
cancer symptoms.6 8 9 The non-specific nature of
ovarian cancer symptoms (such as bloating or lower
back pain)10 11 may make it difficult to discern when
a bodily change is serious, potentially contributing to
non-recognition of symptom seriousness or symptom
misattribution. Fear of cancer has also been found to
increase time to help-seeking, while there is inconclu-
sive evidence for the effects of age.8 Factors that may
encourage prompt help-seeking include fewer per-
ceived barriers to help-seeking7 and a personal experi-
ence of cancer.8
Much of the literature on time to help-seeking uses
an arbitrary time-point cut-off to define ‘delay’ (such
as 3 months or more).12 However, this can be prob-
lematic as a single cut-off point cannot be appropri-
ately applied across all symptoms and cancers.13
Research to date has not specifically explored vari-
ables that might predict a longer time to help-seeking
for symptoms that may indicate ovarian cancer. Doing
so is key to identifying modifiable factors that could
be targeted by interventions aimed at reducing time to
help-seeking. To address this gap, we tested the
hypotheses that lower symptom awareness, personal
experience of cancer, more perceived emotional bar-
riers (including ‘fear’) and/or more perceived practical
barriers to help-seeking would be associated with a
longer anticipated time to help-seeking for symptoms
of ovarian cancer.
We were unsure of the direction of the relationship
between age and help-seeking due to inconsistent or
inconclusive previous findings. Consequently we
made no specific hypotheses with regard to this vari-
able. As the incidence of ovarian cancer begins to rise
at around age 45 years,14 we tested the above hypoth-
eses both in a population-based sample of women
aged 16 years and over, and in a subgroup of women
aged ≥45 years.
METHODS
Recruitment
As part of the Target Ovarian Cancer Pathfinder
Study,15 females aged ≥16 years were recruited via
Synovate (a global market research company) using
random digit dialling. Quotas (i.e. target recruitment
numbers for specific demographic groups) were used
to achieve a population-based sample of women from
different age groups, regions and working statuses.
A total of 1000 women were interviewed over the tele-
phone by Synovate interviewers, using landlines only.
[NB. Synovate does not record the number of people
approached in order to fulfill quota samples.]
Respondents were interviewed for approximately 15
minutes using the Ovarian Cancer Awareness Measure
(Ovarian CAM).16 The Ovarian CAM is a site-specific
version of the generic Cancer Awareness Measure.17
The Ovarian CAM was specifically designed and vali-
dated to be used for both telephone and face-to-face
surveys;16 we used telephone interviews as this allowed
faster and relatively inexpensive data collection.
Measures
Symptom awareness
Respondents were asked one open question and a set of
closed questions to measure awareness of ovarian cancer
symptoms. The open question measured recall and
read: “There are several warning signs and symptoms of
ovarian cancer. Please name as many as you can think
of”. The closed questions measured recognition and
read: “The following may or may not be warning signs
for ovarian cancer. We are interested in your opinion”.
Respondents were read a list of ten known symptoms of
ovarian cancer taken from the Department of Health’s
(DH) Key Messages for ovarian cancer for health pro-
fessionals.10 Response options to each symptom were
‘yes’, ‘no’ or ‘don’t know’. The full list of symptoms
included are given in Table 1.
Table 1 Recalled and recognised ovarian cancer symptoms
Overall sample (n=1000) Subgroup* (n=510)
Ovarian cancer symptom
Recalled Recognised Recalled Recognised
[n (%)] [n (%)] [n (%)] [n (%)]
Persistent pain in abdomen 238 (24) 837 (84) 132 (26) 409 (80)
Persistent pain in pelvis 96 (10) 867 (87) 55 (11) 431 (84)
Persistent bloating 91 (9) 683 (68) 57 (11) 329 (65)
Extreme fatigue 35 (4) 703 (70) 17 (3) 359 (70)
Increased abdominal size 28 (3) 790 (79) 19 (4) 393 (77)
Back pain 28 (3) 706 (71) 21 (4) 368 (72)
Changes in bowel habit 24 (2) 569 (57) 16 (3) 280 (55)
Passing more urine than usual 9 (<1) 450 (45) 4 (<1) 205 (40)
Feeling full persistently 6 (<1) 450 (45) 5 (1) 253 (50)
Difficulty eating on most days 8 (<1) 247 (25) 3 (<1) 105 (21)
*Subgroup of women aged ≥45 years.
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Responses to the open question were recorded verba-
tim and coded into a framework by Synovate inter-
viewers. Thirty-five different codes were generated.
Coding was checked for accuracy by a separate Synovate
team who specialise in coding interviews. For ease of
analysis, and to allow comparisons between numbers of
recalled and recognised symptoms, we only report here
those responses from the open question that corre-
sponded with the closed question list of symptoms.
Each open question response was dichotomised into
‘recalled’ (mentioned) or ‘not recalled’ (not mentioned).
Each closed question response was dichotomised into
‘recognised’ (response ‘yes’) or ‘not recognised’
(responses ‘no’/‘don’t know’). For both questions, scores
were summed to give total ‘symptom recall’ and
‘symptom recognition’ scores.
Barriers
Respondents were read a list of ten barriers and the
question: “Sometimes people put off going to see the
doctor, even when they have a symptom that they think
might be serious. These are some of the reasons people
give for delaying. Could you say if any of these might
put you off going to the doctor?” Responses were
dichotomised into ‘yes’ (responses ‘yes sometimes’/‘yes
often’) and ‘no’ (responses ‘don’t know’/‘no’). As previ-
ously described,7 barriers were grouped into emotional,
service and practical barriers (Table 2). Responses were
summed to give total scores for each group of barriers.
Scores were in the range 0–4 for emotional barriers,
0–3 for service barriers and 0–3 for practical barriers.
Anticipated time to help-seeking
For each symptom from the closed list, respondents
were asked: ‘How soon would you contact your
doctor to make an appointment to discuss it?”. There
were ten response options on an ordinal scale ranging
from ‘1–3 days’ to ‘never’. For ease of analysis we
coded each time period in ascending order from 0 to
10 to measure anticipated time to help-seeking. We
dichotomised the sample into those who anticipated
waiting more or less time before help-seeking for each
symptom. To do this, we calculated the median antici-
pated time to help-seeking for each symptom (using
the scale from 0 to 10) and then dichotomised
responses into a ‘longer anticipated time to help-
seeking’ (>median; score=1) and a ‘shorter antici-
pated time to help-seeking’ (≤median; score=0). We
used a dichotomy as opposed to a continuous variable
as the increments in time periods were unequal,
making it an ordinal rather than an interval scale.
Dichotomising the sample in this way allowed us to
identify those women who were likely to wait longer
than average before seeking help for each of the symp-
toms, rather than focusing on the length of time to
help-seeking, as we acknowledge that responses may
not reflect actual responses to symptoms. Scores for
each symptom were summed to create a scale of
anticipated time to help-seeking (range 0–10). A
higher score indicated that the respondent would
anticipate waiting longer than the median before
seeking help for a greater number of symptoms.
Demographic characteristics
Age was measured as a continuous variable. We
created a subgroup of women aged ≥45 years for ana-
lysis who were at high risk of developing ovarian
cancer due to their age (incidence of ovarian cancer
begins to increase at this age).14
Table 2 Endorsement of barriers to seeking medical help for a symptom that might be serious
Overall (n=1000) Subgroup† (n=510)
Barrier [n (%)]* [n (%)]*
Emotional barriers
Worry what the GP might find 343 (34) 145 (29)
Too scared 209 (21) 77 (15)
Too embarrassed 138 (14) 38 (8)
No confidence in talking to GP about symptom 127 (13) 37 (7)
Practical barriers
Too busy 296 (30) 102 (20)
Too many other things to worry about 267 (27) 116 (23)
Difficult to arrange transport to GP 48 (5) 22 (4)
Service barriers
Difficult to make an appointment with GP 315 (32) 135 (27)
Wasting GP time 303 (30) 120 (24)
GP difficult to talk to 131 (13) 44 (9)
*Respondents were able to endorse more than one barrier.
†Subgroup of women aged ≥45 years.
GP, general practitioner.
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Socio-economic status (SES) was categorised into
low (score=0–1), medium (score=2) and high
(score=3) based on a combined index incorporating
education level, car ownership and home ownership.
This index was used as it is recommended for a
sample including older, retired respondents.18 One
point is given for owning a home, having a car and
having any formal education (score range 0–3).
As only 7.1% of respondents were non-White, these
ethnicities were grouped together and the sample was
dichotomised into ‘White’ or ‘non-White’.
Respondents were asked whether they had known a
close family member, close friend or partner with
cancer. Responses were dichotomised into ‘yes’
(score=1) or ‘no/don’t know’ (score=0) and summed
to give a score of ‘cancer experience’ (range 0-3).
Respondents were also asked whether they had
experienced cancer themselves (‘no’ or ‘yes’).
Analyses
Data were analysed using SPSS version 19 (IBM
Corporation, New York, NY, USA). To select variables
for the multivariate models, we first used bivariate
analyses (not shown here) to test for significant asso-
ciations between anticipated time to help-seeking and
our hypothesised predictor variables as well as demo-
graphic factors. Ethnicity, SES, practical and service
barriers were associated with time to help-seeking in
the sample as a whole and additionally, emotional bar-
riers in the subgroup. Symptom knowledge and
cancer experience showed no association with time to
help-seeking.
Demographic variables (SES, ethnicity and age) and
variables that were significantly associated with antici-
pated time to help-seeking were entered into two mul-
tiple linear regressions (using the sample as a whole and
the subgroup of women aged ≥45 years) to identify sig-
nificant independent predictors of score on the scale.
Linear regressions were used as the skewness and kurto-
sis of the outcome variable (number of symptoms parti-
cipants anticipated waiting longer for) were both within
normal distribution ranges (−1 to 1+). Small sampling
weights were applied to adjust for non-response bias in
terms of government office region, age and occupa-
tional status.
RESULTS
Sample demographics
The mean age of the sample was 47 (range 16–91)
years. Most respondents were White (93%) and
around half were high SES (54%). Almost two-thirds
(63%) of the women had known someone close with
cancer, but few (5%) had experienced cancer them-
selves. The subgroup of women aged ≥45 years
(n=510) had a mean age of 62 (range 45–91) years.
Again, most were White (97%) and high SES (60%).
Nearly three quarters (72%) had known someone
with cancer.
Symptom awareness
Symptom recall was low, with 58% of the whole
sample and 54% of the subgroup of women aged
≥45 years unable to recall any of the 10 symptoms
listed in Table 1 [mean number of symptoms recalled
(M)=0.6/10 for the whole sample, standard deviation
(SD)=0.8 and M=0.6/10, SD=0.9 in the older sub-
group]. ‘Pain in the abdomen’ was the most com-
monly recalled symptom in both the sample overall
and in the subgroup (24% and 26%, respectively).
‘Feeling full’ was the least recalled overall (<1%) and
in the subgroup it was ‘difficulty eating on most days’
(<1%). Recognition scores were much higher with
almost all (99%) able to identify at least one of the 10
symptoms in the overall sample (M=6.3, SD=2.2)
and in the subgroup (M=6.1, SD=2.2). Recognition
was lowest for ‘difficulty eating’ (25% in the overall
sample; 21% in the subgroup) and highest for ‘pain in
pelvis’ (87% in the overall sample; 84% in the sub-
group) (Table 1).
Barriers
Respondents endorsed few barriers to help-seeking
(M=2.2/10, SD=2.2 for the sample overall; M=1.6/
10, SD=1.8 for the subgroup). A quarter (26%) of the
overall sample anticipated no barriers, whilst the figure
was higher (34%) for women aged ≥45 years. The most
endorsed barrier was worry about what the general
practitioner (GP) might find (34% for the sample
overall; 29% for the subgroup) and the least endorsed
was difficulty arranging transport to the GP (5% for the
sample as a whole; 4% for the subgroup) (Table 2).
Anticipated time to help-seeking
Median anticipated time to help-seeking varied by
symptom. Women anticipated waiting the longest for
extreme fatigue, persistent bloating, back pain, persist-
ently feeling full and changes in bowel habit. The
shortest anticipated time was for persistent abdominal
pain. Patterns were the same for the overall sample
and the subgroup (Figure 1 shows median time to
help-seeking by symptom for the sample overall).
The regression model for the sample overall explained
6% of variance in scores on the scale of anticipated time
to help-seeking [Adj R2=0.06, F(5,940)=13.53,
p<0.001]. Endorsing more practical and service barriers
and having a higher SES were significant predictors of a
higher score on the scale (i.e. longer anticipated time to
help-seeking for more symptoms). The standardised
beta was largest for practical barriers (beta=0.16,
p<0.001) and slightly smaller for SES (beta=0.12,
p<0.001) and service barriers (beta=0.10, p<0.01),
suggesting that perceiving more practical barriers to
help-seeking has the strongest influence on anticipated
time to help-seeking.
The regression model for the subgroup explained
11% of the variance in scores on the scale of antici-
pated time to help-seeking [Adj R2=0.11, F(6,458)
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=10.56, p<0.001]. Endorsing more practical and
service barriers, having a higher SES and being of a
White ethnicity all significantly predicted a higher
score. The standardised beta was largest for SES
(beta=0.22, p<0.001) and smaller for service barriers
(beta=0.17, p=0.001), practical barriers (beta=0.13,
p<0.01) and ethnicity (beta=0.12, p<0.01), suggest-
ing that, in the subgroup of women aged ≥45 years,
SES has the strongest influence on anticipated time to
help-seeking. Table 3 contains both regressions.
DISCUSSION
To our knowledge, this study is the first to systematic-
ally measure anticipated time to help-seeking for
ovarian cancer symptoms and to identify variables
associated with a longer time to help-seeking specific-
ally for this cancer in a UK sample. This work is
important, as 1-year survival rates for ovarian cancer
are considerably lower in the UK than in comparable
countries,3 suggesting that this cancer is diagnosed
later in the former and it has been argued that early
diagnosis may be improved through prompt patient
presentation with symptoms.19
This is also the first study that has attempted to
measure awareness of a comprehensive list of ovarian
cancer symptoms in a UK population and to identify
symptoms that are more versus less well known.
Given that previous research has found that misattrib-
uting symptoms of ovarian cancer to benign or coex-
isting conditions led to a longer time to help-seeking,6
it is important that we are aware of the current levels
of awareness and can identify areas for improvement
in knowledge.
Ovarian cancer symptom recall was very low
(overall M=0.6/10; subgroup M=0.6/10), whereas
recognition was considerably higher, reflecting previ-
ous findings using recall and recognition to measure
cancer symptom awareness.7 20–22 This disparity may
be a product of the increased complexity of the cogni-
tive processes required for recall, compared to those
involved in recognition, which may, on occasion, be
influenced by guessing.23 Nevertheless, on average
women were still only able to recognise just over half
Figure 1 Median anticipated time to help-seeking by symptom for the sample overall (n=1000).
Table 3 Multiple linear regression analyses showing predictors
of longer time to help-seeking
Predictor
Overall sample
(n=946)*
Subgroup
(n=504)*
Beta† SE p Beta† SE p
Constant – – 0.014 – – 0.529
Age 0.06 0.03 0.064 0.01 0.05 0.802
Ethnicity 0.07 0.04 0.075 0.12 0.04 0.008
SES 0.12 0.05 0.000 0.22 0.05 0.000
Practical barriers 0.16 0.04 0.000 0.13 0.05 0.008
Service barriers 0.10 0.05 0.005 0.17 0.05 0.001
Emotional barriers – – – 0.04 0.05 0.413
Overall sample Adj R2=0.06, p<0.001; subgroup Adj R2=0.11, p<0.001.
NB. Ethnicity is a categorical variable, coded as Non-white=0, White=1
and SES is an ordinal variable, coded as Low=0, Mid=1 and High=2.
*Sample sizes are smaller due to missing data.
†Standardised.
SE, standard error; SES, socio-economic status.
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of the symptoms (overall M=6.3/10; subgroup
M=6.1/10) when prompted, suggesting that there is a
need for improvement in awareness of symptoms
potentially indicative of ovarian cancer.
Furthermore, as symptoms for ovarian cancer can
be non-specific10 11 it might be pertinent for any
interventions designed to increase awareness to focus
on the characteristics of the symptoms experienced as
well as their presence. For example, there is evidence
that symptoms such as abdominal pain, pelvic pain,
bloating, constipation, and increased abdominal size
are significantly more severe and frequent in women
with ovarian cancer than in women in a general clinic
population.24
Symptoms for which the lowest recognition was
observed were frequent urination (overall=45%;
subgroup=40%), feeling full (overall=45%; sub-
group=40%) and difficulty eating (overall=25%;
subgroup=21%). Research suggests that these symp-
toms (as well as abdominal and pelvic pain) are present
in earlier-stage ovarian cancers;25–28 consequently con-
sideration of these symptoms as potential ovarian
cancer symptoms could aid earlier diagnoses. That
awareness was lowest for these symptoms, then, is con-
cerning. On average a GP will only see one case of
ovarian cancer every 5 years,29 30 which may reduce the
likelihood of GP consideration of ovarian cancer in a
patient presenting with such symptoms. However, if
awareness were higher in women overall, this could
increase the chances of the patient herself considering
ovarian cancer, and therefore being able to highlight
this to her GP upon presentation.
In contrast to our hypothesis, we found no association
between symptom awareness and anticipated time to
help-seeking. This finding does not necessarily mean
that symptom awareness has no influence on time to
help-seeking, however. Symptom awareness may influ-
ence attribution or appraisal behaviour (which has been
shown to be related to time to help-seeking),8 rather
than having a direct relationship with time to help-
seeking. This relationship should be explored further to
aid our understanding of the complexities of help-
seeking behaviour for ovarian cancer symptoms.
It was promising that women anticipated seeking
help quickest for persistent abdominal pain as this is
one of the three most important symptoms high-
lighted to health professionals in the DH’s Key
Messages on ovarian cancer,10 and has been found in
up to 49% of early-stage (I/II) invasive epithelial
ovarian cancer cases31 (90% of ovarian cancers are
this type).32 Previous research exploring symptom
presentation in primary care found that abdominal
pain was one of the most common symptoms
reported.24 This finding, taken together with our own
results, suggests that women may feel comfortable
presenting with abdominal pain and consequently
may not anticipate a reason to wait before seeking
help for this symptom.
Women in both the sample overall and the subgroup
at increased risk (those aged ≥45 years) anticipated
waiting the longest for extreme fatigue, persistent
bloating, back pain, persistently feeling full and
changes in bowel habit. All of these symptoms are
mentioned in the DH’s Key Messages,10 which high-
light persistent bloating and persistently feeling full as
two of the three most important symptoms.
Abdominal bloating and loss of appetite (represented
here as persistently feeling full) have been found to
have positive predictive values (PPVs) for ovarian
cancer of 0.3% and 0.6%, respectively. When paired,
these two symptoms have a PPV of 3.3%, second only
to the pairing of loss of appetite and abdominal dis-
tension (PPV>5%).26 Although these PPVs are not
high (possibly owing to a high frequency of these
symptoms in the general population),33 34 bloating or
feeling full have been found to be present in over
44% of early stage disease.31
Further, Olson and colleagues25 found that 71% of
ovarian cancer patients reported experiencing bloating
and/or fullness in the 6–12 months prior to diagnosis;
similar results to those reported by Goff et al. 3 years
later.24 Consequently, if a patient presents with both
symptoms, it may help a GP to more accurately either
diagnose or refer, particularly if the patient is aged ≥45
years, given that these symptoms are more likely to be
associated with ovarian cancer with increasing age.14
Encouraging earlier help-seeking for these two symp-
toms specifically, particularly in older women, may
impact on diagnoses of less advanced disease.
The amount of variance explained by the regression
models was relatively small, suggesting that there are
other factors that are important in anticipated time to
help-seeking. However we did identify some important
predictor variables. In the overall sample and in the sub-
group, more perceived practical barriers predicted a
higher score on the scale of anticipated time to help-
seeking (indicating a longer time to help-seeking for
more symptoms), supporting previous research explor-
ing help-seeking for ‘generic’ cancer symptoms.35 In
contrast to the findings in the latter research, we also
found that endorsing more perceived service barriers
was a significant predictor of a higher score on the scale
of anticipated time to help-seeking, whereas endorsing
more emotional barriers was not. This finding may be
due to the low awareness that these symptoms could be
indicative of ovarian cancer, leading women to assume
that these symptoms were not significant enough to
merit the difficulty of arranging a doctor’s appointment.
An interesting finding was that women from lower
SES and non-White ethnic groups anticipated seeking
help earlier for more symptoms of ovarian cancer than
those from higher SES and White ethnic backgrounds.
This finding reflects earlier research7 36 and there is
evidence that these relationships between ethnicity and
SES and help-seeking also apply to actual help-seeking
behaviour.37 However, women from lower SES and
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non-White ethnic backgrounds are more frequently
diagnosed with later-stage cancer compared to those
from higher SES and White backgrounds.38–40 The dis-
parity in primary care help-seeking and stage of diag-
nosis between White and non-White ethnicities may be
a result of GP time to referral and diagnosis,37 which
in turn may be a product of the lower ovarian cancer
incidence rates observed in Asian and Black ethnicities
when compared to the White ethnic group.41 Ovarian
cancer cases are rare in primary care;29 30 if few of
those cases are in women of non-White ethnicities, this
may lead to a much reduced possibility that a GP will
even consider an ovarian cancer diagnosis in these
women even if they present promptly with symptoms.
In contrast, however, no such difference has been
observed in incidence for ovarian cancer between SES
groups.42 Consequently, the disparity in SES groups
warrants further investigation.
Study strengths and limitations
This study was strengthened by the use of a validated
tool to measure awareness and anticipated help-
seeking behaviours. If this tool is utilised in future
research, it will allow researchers to identify shifts or
differences in patterns of help-seeking by accurately
comparing these data with other time periods or
other countries. Although the sample was not popula-
tion representative, we collected data from a range of
women from different age and demographic groups.
Consequently, it is likely that the relationships found
in our results would apply to the UK population.
A potential limitation of this study is the measure-
ment of help-seeking intention for a hypothetical
symptom as opposed to actual help-seeking behaviour
for an existing symptom. Although it is unlikely that
anticipated help-seeking would map exactly onto
actual behaviour, this was a pragmatic method that
allowed us to explore the correlates of anticipated
help-seeking in a large sample. Measuring true help-
seeking behaviour is notoriously difficult, whether
retrospective or prospective designs are used.
A second limitation is that questions were asked
within the context of ovarian cancer and it is likely
that women anticipated faster help-seeking than
would occur in a real-life situation where the
symptom might not be appraised as a warning sign of
cancer. For example, the longest median anticipated
time to help-seeking was 2 weeks. However, we
limited the impact of this issue by looking at median
time to help-seeking for each symptom and thus
explored the relative speed of help-seeking behaviour
for each symptom, rather than the time period itself.
Further, DH guidelines for patients29 do not give
advice on how long women should wait before
seeking medical help for symptoms potentially indica-
tive of ovarian cancer. Although DH10 and National
Institute for Health and Clinical Excellence43 guide-
lines mention persistency as a key feature for health
professionals to look for, for a number of symptoms
(such as pelvic or abdominal pain, abdominal disten-
sion and difficulty eating or feeling full quickly) they
do not define ‘persistency’, therefore making it diffi-
cult to say how long women should wait before
seeking help for these symptoms.
A further limitation applicable to our measure was
that we did not investigate frequency, severity or
novelty of hypothetical symptoms, and their impact
on intention to seek help. Doing so would have been
interesting, as symptoms that are frequent, severe and
novel are more likely to indicate ovarian
cancer.8 10 24 27 43 Finally, coding of the open recall
items was carried out by Synovate researchers, and as
some symptoms could potentially be viewed as being
similar (for example ‘persistent bloating’ and
‘increased abdominal size’) it is possible that there was
some coding error. This may have resulted in our esti-
mates of knowledge being too conservative.
Quota sampling was used because it is an efficient
and practical method of collecting data. However, this
method limits the generalisability of the findings.
Despite this, the study was well-powered and novel
and it provides us with an indication of the factors
that may influence time to help-seeking, as well as an
idea of the relative levels of awareness of different
ovarian cancer symptoms in a UK female population.
CONCLUSIONS
This study suggests that there is low awareness of
ovarian cancer symptoms in this population and vari-
ation in anticipated help-seeking behaviour for these
symptoms. Women anticipated waiting longest for per-
sistent bloating and persistently feeling full, symptoms
that are both associated with ovarian cancer, and have
been found in just under half of early-stage cases.
Although barriers may be important in predicting
help-seeking, there may be more important variables
involved that were not measured here. Consequently,
there is a need for more in-depth, exploratory
research to identify these factors.
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